Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials
Kiadis Pharma has received approval to test in the UK an immune therapy to address…
Kiadis Pharma has received approval to test in the UK an immune therapy to address…
Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are…
Evotec teamed up with Merck to boost its drug discovery services with CRISPR, entering the…
Eppendorf joins a Horizon 2020 consortium to support bioreactor development for stem cell cultivation for…
Axiogenesis and Metrion Biosciences will use stem cells to improve preclinical neurotoxicity and cardiac safety…
Here's a neat infographic from Cancer Research UK summarizing a new Cell report from UK researchers that describes how…
Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position…
MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune…
OxStem's strategy for stem cells therapy inside the body could have a big impact in…
This week we depart from East Germany and head south, through both Liechtenstein and…
The Karolisnka Institutet (Sweden) is ready to make History by conducting the first study involving…
Novartis, the Swiss Acquisition-Giant from Basel, has once again taken bought a small chunk of…